TRIM5 as a promising diagnostic biomarker of hepatocellular carcinoma: integrated analysis and experimental validation
Authors:
- 22 March 2024
- journal article
- research article
- Published by Springer Nature in Functional & Integrative Genomics
- Vol. 24 (2) , 1-17
Abstract
The TRIM family is associated with the membrane, and its involvement in the progression, growth, and development of various cancer types has been researched extensively. However, the role played by the TRIM5 gene within this family has yet to be explored to a great extent in terms of hepatocellular carcinoma (HCC). The data of patients relating to mRNA expression and the survival rate of individuals diagnosed with HCC were extracted from The Cancer Genome Atlas (TCGA) database. UALCAN was employed to examine the potential link between TRIM5 expression and clinicopathological characteristics. In addition, enrichment analysis of differentially expressed genes (DEGs) was conducted as a means of deciphering the function and mechanism of TRIM5 in HCC. The data in the TCGA and TIMER2.0 databases was utilized to explore the correlation between TRIM5 and immune infiltration in HCC. WGCNA was performed as a means of assessing TRIM5-related co-expressed genes. The "OncoPredict" R package was also used for investigating the association between TRIM5 and drug sensitivity. Finally, qRT-PCR, Western blotting (WB) and immunohistochemistry (IHC) were employed for exploring the differential expression of TRIM5 and its clinical relevance in HCC. According to the results that were obtained from the vitro experiments, mRNA and protein levels of TRIM5 demonstrated a significant upregulation in HCC tissues. It is notable that TRIM5 expression levels were found to have a strong association with the infiltration of diverse immune cells and displayed a positive correlation with several immune checkpoint inhibitors. The TRIM5 expression also displayed promising clinical prognostic value for HCC patients.Keywords
Funding Information
- the Postgraduate Research & Practice Innovation Program of Jiangsu Province ((KYCX22_3568))
- National Natural Science Foundation of China ((Grant No. 81871909, 82203716), (Grant No. 81871909, 82203716))
- Provincial-level discipline leader of the NJPH ((DTRA202214))
- Cross-cooperation special projects of the NJPH ((YJCHZ-2021-08))
- Beijing iGandan Foundation ((GDXZ-08-19))
- the “13th five-year Plan” Science and Education strong Health Project Innovation team of Yangzhou ((LJRC20181; YZCXTD201801), (LJRC20181; YZCXTD201801), (LJRC20181; YZCXTD201801))
- Yangzhou Key Social Development Project ((YZ2022093), (YZ2022093))
This publication has 60 references indexed in Scilit:
- The tumor microenvironmentCurrent Biology, 2020
- TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signalingEuropean Journal of Pharmacology, 2019
- Tripartite motif-containing protein 7 regulates hepatocellular carcinoma cell proliferation via the DUSP6/p38 pathwayBiochemical and Biophysical Research Communications, 2019
- Goals and targets for personalized therapy for HCCHepatology International, 2019
- Fates of CD8+ T cells in Tumor MicroenvironmentComputational and Structural Biotechnology Journal, 2018
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival AnalysesNeoplasia, 2017
- Upregulated TRIM32 correlates with enhanced cell proliferation and poor prognosis in hepatocellular carcinomaMolecular and Cellular Biochemistry, 2016
- Over-expression of TRIM37 promotes cell migration and metastasis in hepatocellular carcinoma by activating Wnt/β-catenin signalingBiochemical and Biophysical Research Communications, 2015
- The Gene Ontology (GO) Project: Structured Vocabularies for Molecular Biology and Their Application to Genome and Expression AnalysisCurrent Protocols in Bioinformatics, 2002
- A novel zinc finger coiled-coil domain in a family of nuclear proteinsTrends in Biochemical Sciences, 1992